US Activist Pushes Cawachi Drugstore CEO Out, Eyes Japan Merger May 27

US activist investor Kaname Capital has called for the removal of Cawachi Pharmaceutical’s president and another executive ahead of the company’s June 11 shareholder meeting. The Boston-based firm owns 4% of the Japanese drugstore chain and argues that under current leadership, the company has lost 240 billion yen in shareholder value since 2002 while competitors grew 4 to 14 times larger. Cawachi’s stock jumped 5.9% on the news.

The 24-Year Underperformance Case

Kaname Capital released a 100-page report showing Cawachi’s market value fell from 86.8 billion yen in 2002 to 62.8 billion yen by March 2025. Over the same period, competitors like Cosmos Pharmacy grew revenue 14 times, Tsuruha grew 5 times, and Genki expanded from a small player to roughly Cawachi’s current size. Cawachi’s revenue grew only 1.7 times. The company trades at a price-to-book ratio of 0.59, the lowest among listed drugstore peers. Return on equity and return on invested capital have stayed below the cost of capital throughout the period.

Insider Gains and Related-Party Concerns

Kaname estimates President Shinji Kawachi earned 15.8 billion yen in economic gains from a company he inherited but did not build. The activist flagged 4.9 billion yen in purchases over 16 years from a tea wholesaler run by Kawachi’s brother, a transaction Kaname says appears unfair. Kawachi’s annual pay of 160 million yen ranks highest among listed drugstore executives despite managing the least profitable business. Fixed compensation makes up 70% of his pay, double the Tokyo Stock Exchange Prime market standard of 35%.

What Kaname Wants Next

Kaname proposes removing Kawachi and external director Shigetsu Watanabe, shortening director terms from two years to one year, and establishing an independent strategy committee. The activist suggests two paths forward: sale to a more capable operator or going private under founder family control. Kaname estimates the stock could reach 12,500 yen within three years if operations improve, based on a price-to-book multiple of 1.8 times applied to a book value per share of 7,200 yen. The board has stated opposition to both removal proposals.

Market and Activist Momentum

Cawachi’s stock rose to 3,305 yen intraday, marking its best single-day gain since August 2024. Japan saw 176 activist campaigns in 2025, the highest since records began in 2007. As of May 22, 2026, the year has already seen 104 campaigns, up 25% from the same period last year. Bloomberg reported the activist campaign as part of a broader wave of pressure on Japanese companies. The activist’s full white paper details governance failures and proposes structural remedies.

Final Thoughts

Kaname’s push exposes real governance gaps at Cawachi, with the stock’s 5.9% jump showing investor appetite for change. The June 11 vote will test whether minority shareholders can overcome the founding family’s 41.9% control.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.